| Product Name: | D-Lysine, L-cysteinyl-L-lysylglycylglycyl-L-arginyl-L-alanyl-L-lysyl-L-α-aspartyl-L-cysteinylglycylglycyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl- |
| Synonyms: | D-Lysine, L-cysteinyl-L-lysylglycylglycyl-L-arginyl-L-alanyl-L-lysyl-L-α-aspartyl-L-cysteinylglycylglycyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl-;Adipotide Powder;Weight Loss Peptides Adipotide Adipotide Ftpp |
| CAS: | 859216-15-2 |
| MF: | C111H206N36O28S2 |
| MW: | 2557.21 |
 |
|
| Description | Adipotide, referred to also as FTPP, is an experimental weight loss treatment that's been proven to kill fat cells by starving them of blood supply, so that they die and are reabsorbed into the body, as research on animals showed. Established in 2011 by Dr. Wadih Arap and Renata Pasqualini, FTPP peptide is considered to be a diet and cancer pill.According to research, adipotide is a new and innovative drug that is showing great promise in the area of obesity research. Initially created as cancer treated with the purpose of targeting cancer cells so that they would stop growing, Adipotide peptide has also shown promise of decreasing body weight, as studies in animals showed. |
